CVE:VPT

VentriPoint Diagnostics Stock Forecast, Price & News

C$0.32
-0.02 (-5.97 %)
(As of 07/26/2021 03:59 PM ET)
Add
Compare
Today's Range
C$0.31
C$0.33
50-Day Range
C$0.29
C$0.47
52-Week Range
C$0.07
C$0.67
Volume89,408 shs
Average Volume2.36 million shs
Market CapitalizationC$43.33 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VPT News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.


About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.

Headlines

IIROC Trading Halt - VPT
IIROC Trading Halt - VPT
April 28, 2021 |  markets.businessinsider.com
VentriPoint Diagnostics Ltd.
VentriPoint Diagnostics Ltd.
March 19, 2021 |  barrons.com
News for VentriPoint Diagnostics Ltd
News for VentriPoint Diagnostics Ltd
December 24, 2020 |  markets.businessinsider.com
Wall Street looking strong to open the week
Wall Street looking strong to open the week
October 1, 2020 |  proactiveinvestors.com
VentriPoint Diagnostics Ltd. (VPT.V)
VentriPoint Diagnostics Ltd. (VPT.V)
September 27, 2020 |  finance.yahoo.com
IIROC Trading Resumption - VPT
IIROC Trading Resumption - VPT
September 26, 2020 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











VentriPoint Diagnostics (CVE:VPT) Frequently Asked Questions

What stocks does MarketBeat like better than VentriPoint Diagnostics?

Wall Street analysts have given VentriPoint Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but VentriPoint Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are VentriPoint Diagnostics' key executives?

VentriPoint Diagnostics' management team includes the following people:
  • Dr. George Adams, Exec. Chairman & CEO (Age 69, Pay $178.71k)
  • Mr. Desmond Hirson, Consultant
  • Mr. Victor Hugo C.M.A., CPA, Chief Fin. Officer (Age 51)
  • Mr. Hirotaka Katagiri, CTO & Bus. Devel. Division Director
  • Ms. Jessica Naman, Director of Marketing
  • Mr. Jim Graba, Application Specialist & Chief Trainer

Who are some of VentriPoint Diagnostics' key competitors?

What other stocks do shareholders of VentriPoint Diagnostics own?

What is VentriPoint Diagnostics' stock symbol?

VentriPoint Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VPT."

How do I buy shares of VentriPoint Diagnostics?

Shares of VPT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is VentriPoint Diagnostics' stock price today?

One share of VPT stock can currently be purchased for approximately C$0.32.

How much money does VentriPoint Diagnostics make?

VentriPoint Diagnostics has a market capitalization of C$43.33 million and generates C$36,017.00 in revenue each year.

How many employees does VentriPoint Diagnostics have?

VentriPoint Diagnostics employs 147,000 workers across the globe.

What is VentriPoint Diagnostics' official website?

The official website for VentriPoint Diagnostics is www.ventripoint.com.

How can I contact VentriPoint Diagnostics?

The company can be reached via phone at 416-848-4156.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.